Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The most affordable peptide we offer and one of the best-researched
Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function
The Akt-eNOS branch of this cascade is also documented in BPC-157 research focused on the nitric oxide system specifically (PMID 23755725)
Research Applications & Usage Information IGF-1 LR3 (1 mg) is commonly incorporated into laboratory and preclinical research involving: IGF-1 receptor activation and binding affinity studies Myoblast and muscle cell culture experiments Cellular proliferation and differentiation assays Protein synthesis and anabolic signaling research Intracellular signaling pathway analysis (e.g., PI3K/Akt, MAPK/ERK) Comparative evaluation of native IGF-1 versus long-acting analogs Metabolic regulation and glucose-uptake research models Tissue growth and regenerative pathway investigations All applications are investigational and limited to in vitro or preclinical research settings
